Sponsor:
Cybrexa Therapeutics
Code:
NCT06315491
Conditions
Platinum-resistant Ovarian Cancer
Refractory Ovarian Carcinoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CBX-12
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations